Jonathon B. Cohen, MD, MS
Advertisement
Articles by Jonathon B. Cohen, MD, MS
Recommendations for treating a 68-year-old male with mantle cell lymphoma with a BTK inhibitor once he has relapsed on prior therapy.
Advertisement
Latest Updated Articles
Case Assessment: 68-Year-Old Patient With MCLMay 18th 2020
Relapsed Mantle Cell Lymphoma Treatment LandscapeMay 18th 2020
Initiating Therapy for Mantle Cell LymphomaMay 18th 2020
BTK Inhibitor Toxicities in Mantle Cell LymphomaMay 18th 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Adverse Event Burden Tips TKI Selection in Recurrent Diffuse TGCT
2
Amivantamab-Chemotherapy Shows Longest OS Reported in EGFR Exon 20 NSCLC
3
FDA Approves Lutetium Lu 177 Dotatate Injection for SSTR-Positive GEP-NETs
4
T-DXd Significantly Improves PFS in First-Line HER2-Mutant NSCLC
5